DARUNAVIR

Product Description

Human use. Antiviral for systemic use, protease inhibitor. It is indicated for the treatment of patients with Human Immunodeficiency Virus (HIV-1) infection in combination with other antiretroviral drugs.

SUANFARMA Group

  • ES
  • 2015
    On CPhI since
  • 3
    Certificates
  • 500 - 999
    Employees
Distributor/Import Export
Manufacturer/Innovator

SUANFARMA Group

  • ES
  • 2015
    On CPhI since
  • 3
    Certificates
  • 500 - 999
    Employees
Distributor/Import Export
Manufacturer/Innovator

More Products from SUANFARMA Group

SUANFARMA Group resources

  • Video SUANFARMA - CORPORATE VIDEO

    SUANFARMA was born in Spain in 1993 and is specialized in the development, production and commercialization of ingredients for the pharmaceutical, veterinary, and nutritional sectors. 

    During the last 5 years the company has achieved the highest growth in its history and has acquired 5 new companies in Spain, Portugal, Colombia and Italy, increasing significantly its industrial and development capacity. SUANFARMA Group is represented by over 650 people, with presence in over 70 countries.

    At SUANFARMA, we are committed to health and innovation. We develop new technologies and processes to offer innovative products, following the trends of the world of health and the needs of our customers. We cover both “super sales” molecules and niche molecules or specialized therapies, controlling the production process from the intermediate to the final product.

Recommended products